Dr. Mauricio Menacho Márquez | Genetics and Molecular Biology | Best Researcher Award

Dr. Mauricio Menacho Márquez | Genetics and Molecular Biology | Best Researcher Award

Dr. Mauricio Menacho Márquez, Investigador Independiente,,CONICET, Argentina

Dr. Mauricio Menacho Márquez, an accomplished researcher in Genetics and Molecular Biology, has been honored with the Best Researcher Award 🎉. As an Investigador Independiente at CONICET, Argentina 🇦🇷, Dr. Menacho Márquez has significantly advanced our understanding of genetic mechanisms and molecular processes 🧬. His groundbreaking work has been recognized globally 🌍, earning him numerous accolades 🏆. With a commitment to scientific excellence and innovation, Dr. Menacho Márquez continues to inspire future generations of researchers 👨‍🔬👩‍🔬, solidifying his reputation as a leading figure in the field of Genetics and Molecular Biology.

PROFILE 📋

Orcid

CURRENT PROFESSIONAL SITUATION 💼

Dr. Mauricio Menacho Márquez is an esteemed Independent Concept Investigator at CONICET and a Professor at Universidad Nacional de Rosario since 2015. He serves as the Deputy Director of IDICER, International Relations Secretary at the Faculty of Medical Sciences, and Scientific Director at the Centro de Investigación y Producción de Reactivos Biológicos. He also leads the Centro de Investigación del Cáncer de Rosario. His research focuses on cancer, drug repositioning, GTPases, synucleins, and resistance 🧬💊🔬. His dedication to advancing medical science is exemplary, contributing significantly to the field of oncology and drug development 🌟📚🏥.

ACADEMIC TRAINING 🎓

🎓 Dr. Mauricio Menacho Márquez boasts an impressive academic background. He graduated in Biotechnology from Universidad Nacional de Rosario, Argentina, on 02/09/1997. Later, he received his License in Biology, officially homologated by the University of Valencia, Spain, on 10/18/2006. He earned his Doctorate from Universidad Politécnica de Valencia, Spain, on 22/11/2007. 🧬📘 His extensive education has laid a solid foundation for his contributions to the field of biotechnology and biology, demonstrating his dedication and expertise. 🥼🔬📚

PRIOR ACTIVITIES OF CIENTIFIC CHARACTER AND TEACHER ACTUATION 🧑‍🏫

Dr. Mauricio Menacho Márquez has an extensive research background. He served as a Superior Laboratory Technician at Fundación Helios, Universidad Nacional de Rosario (1998-1999) 🔬. He then held various research fellowships: at the Departamento de Farmacología, Universidad Nacional de Rosario (2001-2002) 🧪, Unidad de Investigación Hospital Universitario de Canarias, Spain (2002-2004) 🏥, and Instituto de Biología Molecular y Celular de Plantas, Univ. Politécnica de Valencia, Spain (2004-2007) 🌱. Dr. Menacho Márquez was a Post-Doctoral Investigator at the Centro de Investigación del Cáncer de Salamanca (2008-2014) 🧬, and later, he was a First Auxiliary in Genetics at the Faculty of Medical Sciences, Universidad Nacional de Rosario (2014-2017) 🧬📚.

HUMAN RECORD TRAINING📜

Dr. Mauricio Menacho Márquez has made significant contributions in directing various academic theses and research projects. In 2024, he supervised Senior Directors Manuel Baldovino and Pablo Martínez 🌟. In 2023, he guided medical students Manuel Baldovino and Lucas Cáceres 👩‍⚕️👨‍⚕️. From 2021-2023, he led the Master’s specialization in Bioinformatics of Aylén Ávila, achieving outstanding grades 📚🎓. His mentorship spans numerous doctoral theses, including those of Macarena Mamberto and Nahuel Cesatti Laluce, set to complete by 2025 📖🧬. His direction in biotechnological research, particularly at the Cancer Investigation Center of Salamanca, has been highly commendable, earning “Sobresaliente” ratings consistently 🌐🔬.

SCIENTIFIC AND TECHNOLOGICAL FINANCING 💰

Dr. Mauricio Menacho Márquez Rac1 is a leading researcher in cancer therapeutics. His groundbreaking work includes studying new therapies for resistant tumors (PICT 2022-09-00112) and identifying pharmacological targets for colorectal cancer resistant to 5-FU (PEIC I+D 2021). His research on melanoma and neurodegenerative diseases (PICT 2018-00900) and the role of Vav proteins in cancer (PICT 2019-00801) has been pivotal. As Director of multiple projects, he secured funding for drug repositioning and tumor cell metabolism (National Cancer Institute, $500,000) and developed a biomodule for high-quality lab animals ($2,000,000). 🧬💊🎗️🔬🧪

TECHNOLOGICAL PRODUCTION WITH INTELECTUAL PROPERTY CERTIFICATE 📄

🔬✨ Dr. Mauricio Menacho Márquez, along with Xosé R. Bustelo and Citterio C, has made a groundbreaking contribution to cancer treatment. They invented inhibitors of Vav, a novel approach for preparing medicine to treat metastasis. This significant advancement, patented on 15/07/2012, holds promise in the fight against cancer, potentially saving countless lives. The collaborative efforts of these researchers highlight the importance of innovation and dedication in medical research. 👩‍🔬👨‍🔬🧬💊

PUBLICATION TOP NOTES 📑

Dr. Geetha Vaskuri | Pharmaceutical Sciences | Women Researcher Award

Dr. Geetha Vaskuri | Pharmaceutical Sciences | Women Researcher Award

Dr. Geetha Vaskuri, UTHSC, United States

🌟 Meet Dr. Geetha Vaskuri, a trailblazing researcher in Pharmaceutical Sciences from UTHSC, United States! With her groundbreaking work and dedication to advancing medical knowledge, Dr. Vaskuri has become a prominent figure in her field. Her innovative research and contributions have earned her a well-deserved spot in the running for the Women Researcher Award. 👩‍🔬💊 Her commitment to excellence and passion for improving health outcomes make her a standout candidate. We celebrate her remarkable achievements and look forward to seeing her continue to inspire and lead in pharmaceutical research! 🎉👏

PROFILE 📝

Googlescholar, Orcid

ACADEMIC CREDENTIALS 🎓 

Dr. Geetha Vaskuri boasts impressive academic credentials in the field of Pharmaceutics. 🎓 She earned her Ph.D. in Pharmaceutics from the National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India, with a GPA of 8.17, graduating in 2023. 🌟 Before that, she completed her M.S. in Pharmaceutics at the same institution with a remarkable GPA of 9.42, from 2016 to 2018. 📚 Her academic journey began with a B.Pharmacy degree from Shri Vishnu College of Pharmacy, Bhimavaram, India, where she achieved a GPA of 7.75, from 2012 to 2016. 🎉 Her dedication to the field is evident through her outstanding academic achievements. 👏

RESEARCH EXPOSURE 🔬

Dr. Geetha Vaskuri has made significant contributions in pharmacokinetics and drug delivery. 🌟 Her research includes studying nanobodies in hFcRn mice using ELISA, analyzing CO-releasing compounds in plasma by HPLC, and measuring carboxyhemoglobin levels. 💉 Her Ph.D. dissertation, under Dr. Jitender Madan, focused on novel carrier systems for topical COX2 inhibitor delivery. 💊 Her Master’s work, supervised by Dr. Nalini Shastri, assessed polymer properties in Dipyridamole solid dispersions. 📚 Dr. Vaskuri also fabricated pellets with a non-aqueous extrusion process and completed two industrial projects, including a patented novel drug form. 🔬 She has reverse-engineered particle size analyses for major pharmaceutical companies. 🏷️

WORK EXPERIENCE 💼

Dr. Geetha Vaskuri is currently serving as a Postdoctoral Research Scholar at the University of Tennessee Health Science Center (UTHSC) in Memphis, TN, USA, since May 2023 🌟🔬. With her expertise and dedication, Dr. Vaskuri is contributing significantly to advanced research in her field 🧬🔍. Her role at UTHSC reflects her commitment to scientific excellence and innovation 🚀💡. As she continues to explore and expand her research horizons, Dr. Vaskuri’s work promises to make impactful strides in healthcare and science 💪📚.

HANDS ON EXPERIENCE 🛠️

Dr. Geetha Vaskuri specializes in a range of advanced techniques and equipment essential for research and analysis. Her expertise includes Hot Melt Extrusion (HME), microfluidizer, extrusion-spheronizer, and ball mill. 🧪🔬 She also uses probe sonicator, high shear homogenizer, and texture analyzer for precise measurements. 🌀💧 Dr. Vaskuri’s work involves rheometer, ultra centrifuge, and Roche friabilator, alongside Zetasizer and dissolution apparatus. 🧫📏 Her skills extend to microscopy techniques like polarized microscopy, hot stage microscopy, and scanning electron microscope (SEM). 🔬📸 She employs HPLC, DSC, UV spectroscopy, FTIR, Multi-Mode Reader, Western blot apparatus, and more for comprehensive analysis. 📊🔬

ACADEMIC ACHIEVEMENTS 🏆

Dr. Geetha Vaskuri has an impressive academic and research background. 🎓 She received the Senior Research Fellowship from the Department of Pharmaceuticals, Government of India, from August 2020 to December 2022. Prior to this, she was awarded the Junior Research Fellowship from the same department from August 2018 to July 2020. 🏆 Dr. Vaskuri excelled in competitive exams, securing All India Rank 1 in the NIPER JEE-2018 PhD entrance examination, and All India Rank 43 in the NIPER-JEE Masters 2016. She also achieved All India Rank 1 in the Manipal Entrance Test and scored 165/300 in the Central Universities CET 2016. 🚀📚

HONORS & AWARDS 🥇

Dr. Geetha Vaskuri has been honored with the Young Researcher Award 2023 for her groundbreaking research on meloxicam-loaded solid lipid nanoparticles in chitosan gel for osteoarthritis in a rat model. 🌟🏆 She was nominated by the Department of Science & Technology, Government of India, to participate in the 72nd Lindau Nobel Laureate Meeting, focusing on Physiology and Medicine from June 25-30, 2023. 🏅🔬 She secured 1st place for her oral presentation on “Consequence of lipid chain length and functional group on the permeation efficiency of topical SLN gel” at BITS Pilani, Hyderabad on November 25, 2022. 🎤📈 Additionally, she received the Best Oral Presentation award for her work on “Versatility of film-forming topical dermal spray of meloxicam” at the 2nd International Conference on Pharmaceutics & Drug Delivery Systems, Dubai, UAE, from May 16-17, 2022. 🌍💊 Financial assistance for this conference was provided by the SCIENCE & ENGINEERING RESEARCH BOARD (SERB), Department of Science & Technology, Government of India. 💵👏

WORKSHOPS & CONFERENCES 📅

Dr. Geetha Vaskuri has an impressive track record in pharmaceutical research and education! 🌟 She presented her poster on “Pharmacokinetic study of nanosota nanobodies in hFcRn mice” at the Midwest AViDD Center Workshop #4 in Houston, US, in March 2024. 📊 In November 2022, she showcased her work on “Therapeutic Efficacy of Meloxicam Loaded Solid Lipid Nanoparticles Topical Gel in Managing Osteoarthritis in Rats” at Pharmacon 2022 in India. 🧪 Dr. Vaskuri has also coordinated workshops on advanced drug delivery techniques and participated in various conferences and workshops, including those focused on drug discovery, innovations, and quality management. 💡📚

PUBLICATIONS TOP NOTES 📚

Cellulose based polymers in development of amorphous solid dispersions

Microneedle-Based Natural Polysaccharide for Drug Delivery Systems (DDS): Progress and Challenges

Stability characterization for pharmaceutical liposome product development with focus on regulatory considerations: An update

Self healing hydrogels: A new paradigm immunoadjuvant for delivering peptide vaccine

Lipid nanoparticles in topical dermal drug delivery: Does chemistry of lipid persuade skin penetration?

Cocrystals by Design: A Rational Coformer Selection Approach for Tackling the API Problems

Tuning Diffusion Permeability of an Anti-Retroviral Drug, Emtricitabine, via Multicomponent Crystallizations

SNAC for Enhanced Oral Bioavailability: An Updated Review

Film forming topical dermal spray of meloxicam attenuated pain and inflammation in carrageenan-induced paw oedema in Sprague Dawley rats

Does skin permeation kinetics influence efficacy of topical dermal drug delivery system?: Assessment, prediction, utilization, and integration of chitosan biomacromolecule for …